Chang Gung medical foundation technology transfer <Sulfonamide antibiotic (BAKTAR) Profile>to Pharmigene.
Pharmigene cooperated with Taipei Medical University Hospital.
Self-developed for the SARS-CoV-2 Antigen Rapid Test has entered the market.
<Genetic Testing for Common Medications in Children> enter the Taiwan market.